Visby brings point-of-care PCR to the deep south with an appearance at NACCHO360.
We don’t know. The symptoms of the disease are nonspecific, and many people are not even aware they carry the virus. In fact, the CDC estimates that 40% of people with coronavirus symptoms show no symptoms, with other researchers suggesting the rate may be even higher.
Visby Medical™, a leading medical diagnostic company, today announced the appointment of John W. Kuo as the company’s new Chief Legal Officer. An experienced veteran in corporate law, Kuo brings more than 30 years of experience across multiple industries, including nearly 20 years in the healthcare industry.
Expanding critical access to the only single-use, rapid PCR test, at the point of care.
Visby Medical pairs speed with the accuracy of gold-standard PCR testing in a single-use device, so doctors don’t have to fight blind.
A study of the performance of the Visby Medical Sexual Health Test, a single-use, point-of-care PCR device.
PCR’s superpower lies in its super sensitivity, which enables it to sniff out even low levels of a pathogen in minutes. Here’s how it works.
Visby Medical, an infectious disease diagnostic company, received funding from the National Institutes of Health as part of the organization’s Rapid Acceleration of Diagnostics (RADx) program, an initiative that aims to combat SARS-CoV-2 and increase national testing capacity for COVID-19.
Personal PCR could one day become as common as the common cold. In the future, the device will deliver lab accurate results anywhere and to anyone — forever changing our relationship with diagnostics.
Seven-year-old startup emerges from stealth mode, provides adaptable and rapid testing technology to frontline lab personnel fighting the pandemic